SCHEMBL904660

SCHEMBL904660

ClN1CCN(c2ccccc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.57
LMNA P02545 2/20 0.54
SIGMAR1 Q99720 2/20 0.54
HTR3E A5X5Y0 1/20 0.54
HTR3B O95264 1/20 0.54
ADRB1 P08588 1/20 0.54
HTR3A P46098 1/20 0.54
HTR3D Q70Z44 1/20 0.54
HTR3C Q8WXA8 1/20 0.54
CHRNA7 P36544 2/20 0.54
MAPT P10636 2/20 0.54
KCNH2 Q12809 1/20 0.52
DRD2 P14416 2/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
CHRNB2 P17787 1/20 0.50
NFKB1 P19838 1/20 0.50
MAPK1 P28482 1/20 0.50
CHRNA3 P32297 1/20 0.50
CHRNA4 P43681 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11080687 0.98 DRD4 (0.55) DRD4LMNASIGMAR1HTR3EHTR3B
Bicarbonate SCHEMBL11625617 0.91 ALDH1A1 (0.56) DRD4LMNAMAPTMAPK1ALDH1A1
Acetic Acid SCHEMBL28946868 0.88 USP2 (0.53) LMNACHRNA7MAPTMAPK1ALDH1A1
SCHEMBL12418021 0.87 MEN1 (0.50) DRD4CHRNA7CYP3A4MAPK1HSD17B10
SCHEMBL576454 0.87 LMNA (0.67) DRD4LMNASIGMAR1HTR3EHTR3B
SCHEMBL164538 0.87 LMNA (0.67) DRD4LMNASIGMAR1HTR3EHTR3B
SCHEMBL385012 0.87
SCHEMBL576814 0.87 LMNA (0.67) DRD4LMNASIGMAR1HTR3EHTR3B
SCHEMBL16924853 0.87 LMNA (0.67) DRD4LMNASIGMAR1HTR3EHTR3B
SCHEMBL7258870 0.84 LMNA (0.64) DRD4LMNASIGMAR1HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4208177-A1 CELLULAR COMPOSITION FOR TREATMENT OF DISEASES, DISORDERS OR CONDITIONS AND METHOD OF USE Yztherapeutic Performance Ltd. (IL) 2023-07-12 EP claimed
CN-111886235-B Continuous process for preparing trazodone 方济各安吉利克化学联合股份有限公司 2023-06-30 CN claimed
CN-111795963-B Method for chromogenic detection of piperazine novel psychotropic active substances 福建警察学院 2022-05-03 CN claimed
CN-111879767-B Color development test method of piperazine novel mental active substance 福建警察学院 2022-05-03 CN claimed
CN-111879767-A Color development test method of piperazine novel mental active substance 福建警察学院 2020-11-03 CN claimed
CN-111795963-A Method for chromogenic detection of piperazine novel psychotropic active substances 福建警察学院 2020-10-20 CN claimed
CN-108341807-A Piperazine acidamide compound of the skeleton containing benzodioxan and its preparation method and application 平顶山学院 2018-07-31 CN claimed
CN-104230915-B Phenylpiperazine derivatives containing thiazolidinedione and preparation method thereof and purposes 南京大学 2016-08-17 CN claimed
EP-2983473-A2 PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF ALS Mountain Llc (US) 2016-02-17 EP claimed
CN-104230915-A Thiazolidinedione-containing phenylpiperazine derivatives as well as preparation method and applications of thiazolidinedione-containing phenylpiperazine derivatives NANJING UNIVERSITY OF TECHNOLOGY 2014-12-24 CN claimed
EP-1776121-A2 TREATMENT FOR METHAMPHETAMINE ADDICTION AND REDUCTION OF METHAMPHETAMINE USE USING SEROTONIN ANTAGONISTS Omeros Corporation (US) 2007-04-25 EP claimed
WO-2006017861-A2 TREATMENT FOR METHAMPHETAMINE ADDICTION AND REDUCTION OF METHAMPHETAMINE USE USING SEROTONIN ANTAGONISTS OMEROS CORPORATION (US) 2006-02-16 WO claimed
EP-1035833-B1 COMPOSITIONS FOR NASAL ADMINISTRATION ARCHIMEDES DEV LTD (GB) 2005-08-31 EP claimed
US-6342251-B1 Compositions for nasal administration WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINICAL RESEARCH CENTRE LIMITED (GB) 2002-01-29 US claimed
US-20010046519-A1 Compositions for nasal administration WEST PHARMACEUTICAL SERVICES DRUG DELIVERY 2001-11-29 US claimed
EP-1035833-A1 COMPOSITIONS FOR NASAL ADMINISTRATION West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited (GB) 2000-09-20 EP claimed
WO-1999027905-A1 COMPOSITIONS FOR NASAL ADMINISTRATION WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINICAL RESEARCH CENTRE LIMITED (GB) 1999-06-10 WO claimed
US-5788986-A Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression using R enantiomers, S enantiomers, and racemic mixtures of selective serotonin reuptake inhibitor compounds or their active metabolites TRUSTEES OF TUFTS COLLEGE (US) 1998-08-04 US claimed
EP-0003383-B1 4-AMINO-3-SULFONAMIDO PYRIDINE DERIVATIVES A. CHRISTIAENS SOCIETE ANONYME (BE) 1983-02-09 EP claimed
US-4107437-A SEDATIVES, ANTIARRHYTHMIA AGENTS PARCOR (FR) 1978-08-15 US claimed